Return On Equity of Cartesian Therapeutics, Inc. from 31 Mar 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cartesian Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2017 to 30 Sep 2025.
  • Cartesian Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 287%, a 92% increase year-over-year.
  • Cartesian Therapeutics, Inc. annual Return On Equity for 2024 was 138%, a 62% decline from 2023.
  • Cartesian Therapeutics, Inc. annual Return On Equity for 2023 was 366%, a 739% increase from 2022.
  • Cartesian Therapeutics, Inc. annual Return On Equity for 2022 was 44%, a 92% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Cartesian Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 287% +138% +92% 01 Jul 2025 30 Sep 2025
Q2 2025 478% +324% +211% 01 Apr 2025 30 Jun 2025
Q1 2025 119% -118% -50% 01 Jan 2025 31 Mar 2025
Q4 2024 138% -228% -62% 01 Oct 2024 31 Dec 2024
Q3 2024 149% +198% 01 Jul 2024 30 Sep 2024
Q2 2024 154% +198% 01 Apr 2024 30 Jun 2024
Q1 2024 236% +254% 01 Jan 2024 31 Mar 2024
Q4 2023 366% +323% +739% 01 Oct 2023 31 Dec 2023
Q3 2023 -49% -115% -174% 01 Jul 2023 30 Sep 2023
Q2 2023 -44% -129% -152% 01 Apr 2023 30 Jun 2023
Q1 2023 -18% -218% -109% 01 Jan 2023 31 Mar 2023
Q4 2022 44% -470% -92% 01 Oct 2022 31 Dec 2022
Q3 2022 66% -287% -81% 01 Jul 2022 30 Sep 2022
Q2 2022 85% -283% -77% 01 Apr 2022 30 Jun 2022
Q1 2022 200% -309% -61% 01 Jan 2022 31 Mar 2022
Q4 2021 514% -70% -12% 01 Oct 2021 31 Dec 2021
Q3 2021 353% -961% -73% 01 Jul 2021 30 Sep 2021
Q2 2021 368% -1172% -76% 01 Apr 2021 30 Jun 2021
Q1 2021 509% -4306% -89% 01 Jan 2021 31 Mar 2021
Q4 2020 584% +1790% 01 Oct 2020 31 Dec 2020
Q3 2020 1314% +6167% 01 Jul 2020 30 Sep 2020
Q2 2020 1540% +2943% 01 Apr 2020 30 Jun 2020
Q1 2020 4815% +5455% 01 Jan 2020 31 Mar 2020
Q4 2019 -1206% -789% -189% 01 Oct 2019 31 Dec 2019
Q3 2019 -4854% -4619% -1971% 01 Jul 2019 30 Sep 2019
Q2 2019 -1403% -1247% -804% 01 Apr 2019 30 Jun 2019
Q1 2019 -640% -527% -467% 01 Jan 2019 31 Mar 2019
Q4 2018 -417% -307% -277% 01 Oct 2018 31 Dec 2018
Q3 2018 -234% -134% -134% 01 Jul 2018 30 Sep 2018
Q2 2018 -155% -67% -76% 01 Apr 2018 30 Jun 2018
Q1 2018 -113% -37% -48% 01 Jan 2018 31 Mar 2018
Q4 2017 -111% 01 Oct 2017 31 Dec 2017
Q3 2017 -100% 01 Jul 2017 30 Sep 2017
Q2 2017 -88% 01 Apr 2017 30 Jun 2017
Q1 2017 -76% 01 Jan 2017 31 Mar 2017

Cartesian Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 138% -228% -62% 01 Jan 2024 31 Dec 2024
2023 366% +323% +739% 01 Jan 2023 31 Dec 2023
2022 44% -470% -92% 01 Jan 2022 31 Dec 2022
2021 514% -70% -12% 01 Jan 2021 31 Dec 2021
2020 584% +1790% 01 Jan 2020 31 Dec 2020
2019 -1206% -789% -189% 01 Jan 2019 31 Dec 2019
2018 -417% -307% -277% 01 Jan 2018 31 Dec 2018
2017 -111% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.